Weight Loss with Citrullinaemia Type 1 in South Africa

Citrullinaemia Type 1, also called Classic Citrullinaemia or Argininosuccinate Synthetase Deficiency, is a rare urea cycle disorder caused by mutations in the ASS1 gene. The urea cycle is the liver's system for disposing of nitrogen from protein metabolism. In Citrullinaemia Type 1, one step of this cycle is blocked, causing citrulline and ammonia to accumulate in the blood. Ammonia is toxic to the brain — elevated ammonia (hyperammonaemia) causes confusion, vomiting, seizures, and, if severe, coma and death. If you have Citrullinaemia Type 1 and want to manage your weight safely, this guide explains the biochemistry, why protein restriction must be precise, the paradoxical role of arginine supplementation, and how to create a safe caloric deficit without triggering a hyperammonaemic crisis.

The Urea Cycle and Where Citrullinaemia Type 1 Fits

When the body breaks down dietary protein, amino acids release nitrogen in the form of ammonia (NH₃). Free ammonia is highly toxic, especially to the brain. The liver disposes of ammonia via the urea cycle — a series of five enzymatic reactions that convert ammonia to urea, which is then excreted by the kidneys in urine. The five steps and their enzymes are:

1. CPS1 (Carbamoyl Phosphate Synthetase 1): Converts ammonia + bicarbonate + 2 ATP → carbamoyl phosphate (inside mitochondria).
2. OTC (Ornithine Transcarbamylase): Combines carbamoyl phosphate with ornithine → citrulline (inside mitochondria). [OTC Deficiency is the most common urea cycle disorder — a separate condition covered in another article on this site.]
3. ASS1 (Argininosuccinate Synthetase 1): Combines citrulline with aspartate → argininosuccinate (in the cytoplasm). This is the step blocked in Citrullinaemia Type 1.
4. ASL (Argininosuccinate Lyase): Cleaves argininosuccinate → arginine + fumarate.
5. ARG1 (Arginase 1): Cleaves arginine → urea + ornithine (ornithine re-enters the mitochondria to restart the cycle).

In Citrullinaemia Type 1, mutations in both copies of the ASS1 gene on chromosome 9q34.1 cause severely reduced or absent ASS1 enzyme activity. Citrulline (the product of step 2) cannot be processed into argininosuccinate (step 3). Citrulline accumulates massively in the blood — plasma citrulline in classic Citrullinaemia Type 1 is typically 1000–5000 micromol/L, compared with the normal range of 10–40 micromol/L. Because the cycle is blocked, nitrogen cannot be disposed of as urea — ammonia accumulates.

Downstream of the block, arginine becomes deficient. Arginine is normally synthesised via steps 3, 4, and 5. In Citrullinaemia Type 1, these steps are blocked, so arginine synthesis is impaired. Arginine becomes a conditionally essential amino acid that must be supplemented.

Two Presentations of Citrullinaemia Type 1

The clinical spectrum of Citrullinaemia Type 1 varies with residual enzyme activity:

• Neonatal/severe classic form: Near-complete ASS1 deficiency. Presents in the first 24–72 hours of life with rapid-onset hyperammonaemia, refusal to feed, vomiting, irritability, seizures, and coma. Without emergency treatment (IV nitrogen scavengers, dialysis), fatal outcomes occur. Neonatal screening identifies these patients in countries with expanded screening programmes before symptoms develop.
• Late-onset/mild form: Residual ASS1 activity. Patients may be asymptomatic or minimally symptomatic for years, sometimes first presenting in adulthood with confusion, headaches, or liver dysfunction — often precipitated by high protein intake, illness, surgery, or prolonged fasting. Some patients with mild forms are not diagnosed until adulthood.

This guide focuses primarily on the dietary management applicable to both forms in patients who are stable and seeking weight management strategies.

Core Dietary Principles: Protein Restriction + Arginine Supplementation

Protein Restriction

Dietary protein is the source of nitrogen that must be processed by the urea cycle. In Citrullinaemia Type 1, the cycle's capacity to handle nitrogen is severely limited. Protein intake must be restricted to the minimum needed for growth and tissue maintenance — typically 0.8–1.2 g/kg/day in adults, with the exact amount individually titrated based on ammonia levels and clinical response.

Natural protein restriction means:

• Limiting meat, fish, poultry, and eggs to prescribed small portions
• Limiting dairy products
• Limiting legumes and soya products
• Often supplementing with a nitrogen-free or low-nitrogen essential amino acid formula to meet protein equivalent needs without excess nitrogen loading

Many patients use amino acid formulas that provide essential amino acids without the excess nitrogen of natural proteins. These are similar to the formulas used in Phenylketonuria and other amino acid disorders, though without specific amino acid restrictions.

Arginine Supplementation — the Paradox

Despite being a urea cycle intermediate, oral arginine supplementation is a core part of Citrullinaemia Type 1 management. This seems counterintuitive, but the logic is as follows:

• Arginine is the precursor to urea (step 5) and to ornithine (which recycles back to step 2). Without arginine synthesis — which is blocked in Citrullinaemia Type 1 — the available ornithine for the cycle diminishes over time, reducing cycle efficiency further.
• Arginine supplementation replenishes the ornithine pool indirectly (via step 5), helping the residual urea cycle capacity function as efficiently as possible.
• Arginine also has a direct nitrogen-capturing effect: each arginine molecule incorporated into this truncated cycle allows one nitrogen molecule to exit as urea (from whatever residual arginase activity exists).

Arginine is typically dosed at 400–700 mg/kg/day in children and adjusted for adults, taken throughout the day with meals. Your metabolic team will have established your dose. Do not reduce or stop arginine without medical advice — it is therapeutic, not just a dietary supplement.

Nitrogen Scavenger Medications

In patients with more severe disease, nitrogen scavenger medications such as sodium benzoate and sodium phenylbutyrate (or the prodrug glycerol phenylbutyrate) are prescribed. These drugs provide alternative pathways for nitrogen excretion via the kidneys, bypassing the blocked urea cycle. These are prescription medications requiring metabolic physician oversight, not dietary supplements.

Weight Management in Citrullinaemia Type 1

The challenge of weight management in Citrullinaemia Type 1 is similar to other urea cycle disorders: protein is restricted, so most caloric intake comes from carbohydrates and fats. Excess consumption of these energy sources leads to weight gain. Additionally:

• Amino acid supplements and some medical formulas contain calories that are easy to overlook.
• Low-protein specialty foods (used to replace protein-dense staples) are often calorie-dense due to their high fat and carbohydrate content.
• Prolonged fasting — even during a caloric deficit — can trigger catabolism of body protein, releasing nitrogen endogenously and precipitating hyperammonaemia. This is the most important risk in weight management.

Safe Weight Loss Strategies

Discuss any weight loss plan with your metabolic physician and dietitian before starting. A modest caloric deficit of 300–400 kcal/day is generally safe in stable adults with well-controlled Citrullinaemia Type 1. More aggressive restriction risks catabolism-induced hyperammonaemia.

• Never skip meals or fast for extended periods: Each fasting period — even overnight — causes some degree of protein catabolism and nitrogen release. Eat small, frequent meals throughout the day. If you cannot eat due to illness, contact your metabolic team immediately for emergency management (usually IV glucose to suppress catabolism).
• Reduce calories from fat, not from protein prescription: Your protein allocation is already at the minimum safe level. Do not reduce it further to create a caloric deficit. Reduce calories by trimming fat from cooking (use less oil, grill instead of fry) and reducing high-calorie low-protein additions like butter, cream, and sugary drinks.
• Control low-protein specialty food portions: Low-protein pasta, bread substitutes, and biscuits are useful for meeting carbohydrate needs without nitrogen loading, but they are calorie-dense. Measuring portions of these foods is typically the most effective way to reduce total caloric intake.
• Choose naturally low-calorie, low-protein vegetables as volume foods: Lettuce, cucumber, green beans, courgettes, cabbage, and broccoli can be eaten in generous quantities. They contribute very little protein or calories while providing fibre, vitamins, and bulk that reduces hunger.
• Stay well-hydrated: Adequate hydration supports urea excretion. Drink at least 2 litres of water daily. Rooibos tea (naturally low in protein and zero nitrogen) is an ideal South African warm drink option.

Warning Signs of Hyperammonaemia

Know these signs and act immediately. In Citrullinaemia Type 1, a hyperammonaemic episode is a medical emergency:

• Persistent nausea, vomiting, or loss of appetite — especially if unusual
• Increasing headache — particularly if accompanied by confusion
• Unusual fatigue, irritability, or behavioural changes
• Slurred speech, unsteady gait, or visual disturbance
• Seizures or loss of consciousness — call emergency services immediately

If you cannot eat during illness — even for 12–24 hours — contact your metabolic team immediately. Emergency management typically involves IV glucose (10% dextrose) at a rate that suppresses protein catabolism, plus IV nitrogen scavengers if available. Many patients with Citrullinaemia Type 1 carry a metabolic emergency card and/or letter explaining their condition to emergency room staff.

Exercise in Citrullinaemia Type 1

Moderate exercise is safe and beneficial in well-controlled Citrullinaemia Type 1. However, exercise should not be done in a fasted state — this combination maximises muscle protein catabolism and nitrogen release. Always:

• Eat a carbohydrate-containing snack before exercise sessions
• Exercise duration should be moderate — 30–45 minutes of moderate-intensity activity
• Avoid prolonged high-intensity exercise that could trigger significant muscle protein breakdown
• Increase fluid intake around exercise to support renal urea excretion

Walking, swimming, cycling, and light resistance training are all appropriate. Competitive endurance events or very high-intensity training regimens should be discussed with your metabolic physician before commencing.

South African Context

Citrullinaemia Type 1 is included in South Africa's expanded newborn screening programmes at some centres — though population-wide screening is not yet universally available. Diagnosis may occur neonatally, in childhood, or occasionally in adulthood following a first hyperammonaemic episode. Metabolic teams at Wits Children's Hospital (Johannesburg), Red Cross War Memorial Children's Hospital (Cape Town), and Steve Biko Academic Hospital (Pretoria) are experienced in urea cycle disorder management.

Sodium benzoate and sodium phenylbutyrate are not always readily available through public sector pharmacies in South Africa — confirm your supply with your metabolic team before travelling to remote areas. Carry emergency management instructions in both English and Afrikaans.

Key Takeaways

• Citrullinaemia Type 1 is caused by ASS1 gene mutations — the urea cycle cannot process nitrogen past the citrulline stage.
• Plasma citrulline is massively elevated; ammonia accumulates if protein intake exceeds the cycle's residual capacity.
• Protein intake must be precisely restricted — never reduce below your prescribed minimum when trying to lose weight.
• Arginine supplementation is therapeutic and essential — it supports residual cycle function.
• Fasting is dangerous — it triggers protein catabolism and endogenous nitrogen release, risking hyperammonaemia.
• A safe weight loss deficit is 300–400 kcal/day, achieved by reducing fats and controlling low-protein specialty food portions.
• Always exercise fed, never fasted.
• Know the signs of hyperammonaemia and treat any episode as a medical emergency.

This article is for educational purposes only and does not replace individualised advice from your metabolic physician or dietitian. Dietary management of Citrullinaemia Type 1 requires specialist metabolic supervision with regular ammonia and amino acid monitoring.